Hearing loss in Pompe disease revisited: Results from a study of 24 children

Journal of Inherited Metabolic Disease

Volumn 33, Issue 5, 2010, Pages 597-602

  Van Capelle, Carine I ^a,b   Goedegebure, Andre ^a   Homans, Nienke C ^a   Hoeve, Hans L J ^a   Reuser, Arnold J ^b   Van Der Ploeg, Ans T ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; GLYCOGEN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONDUCTION DEAFNESS; DISEASE SEVERITY; EARLY INTERVENTION; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 2; HEARING; HEARING AID; HEARING IMPAIRMENT; HUMAN; INFANT; INNER EAR DISEASE; LANGUAGE DEVELOPMENT; MALE; PATIENT MONITORING; PERCEPTION DEAFNESS; PHENOTYPE; PREVALENCE; PURE TONE AUDIOMETRY; SPEECH DEVELOPMENT;

ADOLESCENT; ALPHA-GLUCOSIDASES; AUDIOMETRY, PURE-TONE; CHILD; CHILD, PRESCHOOL; ENZYME REPLACEMENT THERAPY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE II; HEARING LOSS, CONDUCTIVE; HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL; HUMANS; INFANT; INFANT, NEWBORN; LEAST-SQUARES ANALYSIS; MALE; NETHERLANDS; PHENOTYPE; PROSPECTIVE STUDIES; REHABILITATION OF HEARING IMPAIRED; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957562010     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9144-0     Document Type: Article

References (28)

1. DE Bamiou P Campbell A Liasis, et al. 2001 Audiometric abnormalities in children with Gaucher disease type 3 Neuropediatrics 32 136 141 1:STN:280:DC%2BD3MvnslGntA%3D%3D 10.1055/s-2001-16611 11521209 (Pubitemid 32747625)
2. Engel AG, Hirschhorn R et al (2004) Acid maltase deficiency. In: Nogueira I (ed) Myology. McGraw-Hill, New York, pp 1559-1586
3. D Hajioff S Hegemann G Conti, et al. 2006 Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey Eur J Clin Invest 36 663 667 1:CAS:528:DC%2BD28XhtVeqtLzF 10.1111/j.1365-2362.2006.01701.x 16919050 (Pubitemid 44213834)
4. S Hegemann D Hajioff G Conti, et al. 2006 Hearing loss in Fabry disease: data from the Fabry outcome survey Eur J Clin Invest 36 654 662 1:STN:280:DC%2BD28vpsVOgtg%3D%3D 10.1111/j.1365-2362.2006.01702.x 16919049 (Pubitemid 44213833)
5. Jones HN, Muller CW, Lin M et al (2009) Oropharyngeal dysphagia in infants and children with infantile Pompe disease. Dysphagia, Sep 10. [Epub ahead of print]
6. M Kaga C Azuma T Imamura, et al. 1982 Auditory brainstem response (ABR) in infantile Gaucher's disease Neuropediatrics 13 207 210 1:STN:280: DyaL3s7hsFGlsA%3D%3D 10.1055/s-2008-1059624 7155305
7. JH Kamphoven MM de Ruiter LP Winkel, et al. 2004 Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse Neurobiol Dis 16 14 20 10.1016/j.nbd.2003.12.018 15207257 (Pubitemid 38569791)
8. A Keilmann D Hajioff U Ramaswami, et al. 2009 Ear symptoms in children with Fabry disease: data from the Fabry outcome survey J Inherit Met Dis 32 6 739 744 1:STN:280:DC%2BC3c%2FjvVertQ%3D%3D 10.1007/s10545-009-1290-x
9. PS Kishnani WL Hwu H Mandel, et al. 2006 A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease J Pediatr 148 671 676 10.1016/j.jpeds.2005.11.033 16737883 (Pubitemid 43776899)
10. PS Kishnani D Corzo M Nicolino, et al. 2007 Recombinant human acid [alpha] glucosidase: major clinical benefits in infantile-onset Pompe disease Neurology 68 99 109 1:CAS:528:DC%2BD2sXosFSg 10.1212/01.wnl.0000251268.41188.04 17151339 (Pubitemid 46071892)
11. PS Kishnani D Corzo ND Leslie, et al. 2009 Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease Pediatr Res 66 329 335 1:CAS:528:DC%2BD1MXpsFygtrw%3D 10.1203/PDR. 0b013e3181b24e94 19542901
12. Y Komura K Kaga Y Ogawa, et al. 1998 ABR and temporal bone pathology in Hurler's disease Int J Pediatr Otorhinolaryngol 43 179 188 1:STN:280: DyaK1c3jslaguw%3D%3D 10.1016/S0165-5876(97)00176-6 9578128 (Pubitemid 28166671)
13. DJ Lacey K Terplan 1984 Correlating auditory evoked and brainstem histologic abnormalities in infantile Gaucher's disease Neurology 34 539 541 1:STN:280:DyaL2c7kt1Ojsw%3D%3D 6538314
14. GA Mathew G Kuruvilla A Job 2007 Dynamic slow motion video endoscopy in Eustachian tube assessment Am J Otolaryng 28 91 97 10.1016/j.amjoto.2006.06.019 (Pubitemid 46386315)
15. A Palla S Hegemann U Widmer, et al. 2007 Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy J Neurol 254 1433 1442 1:CAS:528:DC%2BD2sXhtlyitb%2FI 10.1007/s00415-007-0575-y 17934877 (Pubitemid 350112336)
16. JE Peck 1984 Hearing loss in Hunter's syndrome-mucopolysaccharidosis II Ear Hear 5 243 246 1:STN:280:DyaL2c3os1CgsA%3D%3D 10.1097/00003446-198407000- 00009 6432613
17. PA Schachern DA Shea MM Paparella, et al. 1989 Otologic histopathology of Fabry's disease Ann Otol Rhinol Laryngol 98 359 363 1:STN:280: DyaL1M3ksFOmug%3D%3D 2497691
18. PA Schachern S Cureoglu V Tsuprun 2007 Age-related functional and histopathological changes of the ear in the MPS I mouse Int J Pediatr Otorhinolaryngol 71 197 203 10.1016/j.ijporl.2006.09.016 17101178 (Pubitemid 46054167)
19. S Strothotte N Strigl-Pill B Grunert, et al. 2009 Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial J Neurol 257 91 97 10.1007/s00415-009-5275-3 19649685
20. BL Thurberg C Lynch Maloney C Vaccaro, et al. 2006 Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease Lab Invest 86 1208 1220 1:CAS:528:DC%2BD28Xht1akurzE 10.1038/labinvest.3700484 17075580 (Pubitemid 44789911)
21. M Tos 1998 Importance of eustachian tube function in middle ear surgery Ear Nose Throat J 77 744 747 1:STN:280:DyaK1M%2FgtlOrtw%3D%3D 9787517
22. CI van Capelle LP Winkel ML Hagemans, et al. 2008 Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease Neuromuscul Disord 18 447 452 10.1016/j.nmd.2008.04.009 18508267
23. HM van den Hout W Hop OP van Diggelen, et al. 2003 The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature Pediatrics 112 332 340 10.1542/peds.112.2.332 12897283 (Pubitemid 36951395)
24. JM Van den Hout JH Kamphoven LP Winkel, et al. 2004 Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk Pediatrics 113 e448 e457 10.1542/peds.113.5.e448 15121988
25. AT van der Ploeg AJ Reuser 2008 Pompe's disease Lancet 372 1342 1353 10.1016/S0140-6736(08)61555-X 18929906
26. WHO (1980) International classification of impairments, disabilities and handicaps: a manual of classification related to the consequences of disease. WHO, Geneva
27. LP Winkel ML Hagemans PA van Doorn, et al. 2005 The natural course of non-classic Pompe's disease; a review of 225 published cases J Neurol 252 875 884 10.1007/s00415-005-0922-9 16133732 (Pubitemid 41186956)
28. Zumach A, Gerrits E, Chenault M et al (2009) Long-term effects of early otitis media on language development. J Speech Lang Hear Res, Jul 27 [Epub ahead of print]